The Chinese University of Hong Kong

🇨🇳China

Country: 🇨🇳China

Ownership: Private

Established: 1963-01-01

Employees: -

Market Cap: -

Website: http://www.cuhk.edu.hk

Clinical Trials

Gastric Functions & Proton Pump Inhibitor( PPI) Study

Phase 4

Completed

Conditions: Functional Dyspepsia

Interventions: Drug: Placebo
Drug: Esomeprazole

First Posted Date: 2009-08-04

Last Posted Date: 2019-02-01

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 155

Registration Number: NCT00951431

Locations: 🇭🇰
Prince of Wales Hospital, Hong Kong, Hong Kong

PEARL Program: Empowerment Program for Patients With Type 2 Diabetes (HK4)

Not Applicable

Completed

Conditions: Diabetes

Interventions: Behavioral: Usual Care
Behavioral: Patient Peer Support and Empowerment

First Posted Date: 2009-08-03

Last Posted Date: 2015-08-25

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 632

Registration Number: NCT00950716

Locations: 🇨🇳
Asia Diabetes Foundation, Hong Kong, China

Validity and Cost-Effectiveness of a New Screening Test for Hepatocellular Carcinoma

Completed

Conditions: Hepatitis B Virus

First Posted Date: 2009-06-03

Last Posted Date: 2009-06-03

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 1018

Registration Number: NCT00912847

A Proof-of-Concept Study of Darbepoetin Alfa in Partial Correction of Anemia in Chinese With Diabetic Nephropathy

Not Applicable

Terminated

Conditions: Diabetes Mellitus
Chronic Kidney Disease
Anemia

Interventions: Drug: Darbepoetin alfa

First Posted Date: 2009-05-22

Last Posted Date: 2009-05-22

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 16

Registration Number: NCT00907608

Locations: 🇨🇳
Prince of Wales Hospital, Hong Kong, China

The Chinese University of Hong Kong Early Arthritis Study

Not Applicable

Completed

Conditions: Rheumatoid Arthritis

Interventions: Drug: Methotrexate
Drug: Infliximab

First Posted Date: 2009-05-14

Last Posted Date: 2012-08-02

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 40

Registration Number: NCT00901550

Locations: 🇨🇳
The Prince of Wales Hospital, Hong Kong, China
🇨🇳
Prince of Wales Hospital, Hong Kong, China
🇨🇳
Department of Medicine and Therapeutics, Hong Kong, China

Effect of Electroacupuncture in Patients With Irritable Bowel Syndrome

Not Applicable

Completed

Conditions: Irritable Bowel Syndrome

Interventions: Device: Electroacupuncture treatment (electrical stimulation machine (EY-3308 Model, G6805-2 Mayfair))
Device: Sham acupuncture treatment (electrical stimulation machine (EY-3308 Model, G6805-2 Mayfair))

First Posted Date: 2009-05-13

Last Posted Date: 2009-07-02

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 42

Registration Number: NCT00900965

Locations: 🇨🇳
The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong, China

Aliskiren for Immunoglobulin A (IgA) Nephropathy

Phase 3

Completed

Conditions: IgA Nephropathy

Interventions: Drug: Aliskiren
Drug: Placebo

First Posted Date: 2009-03-27

Last Posted Date: 2012-12-04

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 22

Registration Number: NCT00870493

Locations: 🇭🇰
Prince of Wales Hospital, Shatin, Hong Kong

Treatment of Nonalcoholic Fatty Liver Disease With Probiotics and Prebiotics

Not Applicable

Completed

Conditions: Nonalcoholic Fatty Liver Disease

Interventions: Other: Simple lifestyle advice
Drug: Lepicol probiotic & prebiotic formula

First Posted Date: 2009-03-26

Last Posted Date: 2014-02-24

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 20

Registration Number: NCT00870012

Locations: 🇨🇳
Cheng Suen Man Shook Hepatitis Center, Institute of Digestive Disease, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China

Low Glycemic Index Dietary Intervention Program in Nonalcoholic Fatty Liver Disease

Not Applicable

Completed

Conditions: Nonalcoholic Fatty Liver Disease

Interventions: Other: Low glycemic index dietary intervention program
Other: simple lifestyle advice

First Posted Date: 2009-03-25

Last Posted Date: 2014-02-24

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 159

Registration Number: NCT00868933

Locations: 🇨🇳
Cheng Suen Man Shook Hepatitis Center, Institute of Digestive Disease, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China

Effects of Isoflavone in Patients With Watchful Waiting Benign Prostate Hyperplasia

Not Applicable

Completed

Conditions: Benign Prostate Hyperplasia

Interventions: Drug: isoflavones (Soylife 25)
Drug: placebo

First Posted Date: 2009-03-13

Last Posted Date: 2009-03-13

Lead Sponsor: Chinese University of Hong Kong

Target Recruit Count: 176

Registration Number: NCT00861588

Locations: 🇭🇰
The Chinese University of Hong Kong, Hong Kong, Hong Kong

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy